Prevalence of smoldering multiple myeloma based on nationwide screening

Autor: Thorsteinsdóttir, Sigrún, Gíslason, Gauti K., Aspelund, Thor, Rögnvaldsson, Sæmundur, Óskarsson, Jón Þórir, Sigurðardóttir, Guðrún Á, Þórðardóttir, Ásdís R., Viðarsson, Brynjar, Önundarson, Páll T., Agnarsson, Bjarni A., Sigurðardóttir, Margrét, Þorsteinsdóttir, Ingunn, Ólafsson, Ísleifur, Eyþórsson, Elías, Jónsson, Ásbjörn, Berlanga, Oscar, Hulcrantz, Malin, Durie, Brian G. M., Löve, Thorvardur J., Harding, Stephen, Landgren, Ola, Kristinsson, Sigurður Y.

Publikováno v: Nature Medicine; 20230101, Issue: Preprints p1-6, 6p

Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre‐ibrutinib era: A population‐based study.

Autor: Steingrímsson, Vilhjálmur, Lund, Sigrún H., Dickman, Paul W., Weibull, Caroline E., Björkholm, Magnus, Landgren, Ola, Kristinsson, Sigurður Y.

Publikováno v: European Journal of Haematology; Feb2022, Vol. 108 Issue 2, p145-153, 9p

Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study.

Autor: Sverrisdóttir, Ingigerður S., Lund, Sigrún H., Turesson, Ingemar, Björkholm, Magnus, Goldin, Lynn R., Landgren, Ola, Kristinsson, Sigurður Y.

Publikováno v: British Journal of Haematology; Jul2019, Vol. 186 Issue 1, p37-44, 8p, 3 Charts

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Autor: Swaminathan, Bhairavi, Thorleifsson, Guðmar, Jöud, Magnus, Ali, Mina, Johnsson, Ellinor, Ajore, Ram, Sulem, Patrick, Halvarsson, Britt-Marie, Eyjolfsson, Guðmundur, Haraldsdottir, Vilhelmina, Hultman, Christina, Ingelsson, Erik, Kristinsson, Sigurður Y., Kähler, Anna K., Lenhoff, Stig, Masson, Gisli, Mellqvist, Ulf-Henrik, Månsson, Robert, Nelander, Sven, Olafsson, Isleifur

Publikováno v: Nature Communications; May2015, Vol. 6 Issue 5, p7213, 1p

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Autor: Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Sud A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Försti A; German Cancer Research Center, 69120, Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden., Halvarsson BM; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden., Weinhold N; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany., Kimber S; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK., van Duin M; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands., Thorleifsson G; deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Holroyd A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK., Li N; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Orlando G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Ali M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden., Chen B; German Cancer Research Center, 69120, Heidelberg, Germany., Mitchell JS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Gudbjartsson DF; deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, IS-101, Reykjavik, Iceland., Kuiper R; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands., Stephens OW; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Bertsch U; German Cancer Research Center, 69120, Heidelberg, Germany.; National Centre of Tumor Diseases, 69120, Heidelberg, Germany., Broderick P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Campo C; German Cancer Research Center, 69120, Heidelberg, Germany., Bandapalli OR; German Cancer Research Center, 69120, Heidelberg, Germany., Einsele H; University Clinic of Würzburg, 97080, Würzburg, Germany., Gregory WA; Clinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK., Gullberg U; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden., Hillengass J; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany., Hoffmann P; Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.; Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003, Basel, Switzerland., Jackson GH; Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK., Jöckel KH; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, D-45147, Germany., Johnsson E; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden., Kristinsson SY; Department of Hematology, Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland., Mellqvist UH; Section of Hematology, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden., Nahi H; Center for Hematology and Regenerative Medicine, SE-171 77, Stockholm, Sweden., Easton D; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK., Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK., Dunning A; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK., Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Swerdlow A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK., Eeles RA; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.; Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Kote-Jarai Z; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Muir K; Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK., Pashayan N; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.; Department of Applied Health Research, University College London, London, WC1E 7HB, UK., Nickel J; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany., Nöthen MM; Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.; Department of Genomics, Life & Brain Center, University of Bonn, D-53127, Bonn, Germany., Rafnar T; deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Ross FM; Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, SP2 8BJ, UK., da Silva Filho MI; German Cancer Research Center, 69120, Heidelberg, Germany., Thomsen H; German Cancer Research Center, 69120, Heidelberg, Germany., Turesson I; Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden., Vangsted A; Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark., Andersen NF; Department of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark., Waage A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway., Walker BA; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Wihlborg AK; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden., Broyl A; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands., Davies FE; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Thorsteinsdottir U; deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Langer C; Department of Internal Medicine III, University of Ulm, D-89081, Ulm, Germany., Hansson M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.; Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden., Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.; National Centre of Tumor Diseases, 69120, Heidelberg, Germany., Kaiser M; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands., Stefansson K; deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Morgan GJ; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Hemminki K; German Cancer Research Center, 69120, Heidelberg, Germany. K.Hemminki@dkfz-heidelberg.de.; Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden. K.Hemminki@dkfz-heidelberg.de., Nilsson B; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.; Broad Institute, 7 Cambridge Center, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2019 Jan 10; Vol. 10 (1), pp. 213. Date of Electronic Publication: 2019 Jan 10.